Kymera Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Watertown, MA
KYMR chart
What traders are saying about $KYMR
Latest postsKymera Therapeutics, Inc. news
- Kymera Therapeutics (NASDAQ:KYMR) Sets New 12-Month High - Time to Buy?
MarketBeat ·
- 9,870 Kymera Therapeutics, Inc. $KYMR Shares Purchased by Kornitzer Capital Management Inc. KS
MarketBeat ·
- Kymera Therapeutics (KYMR) Advances KT 579 And KT 621, Is It Still 6% Undervalued?
Simply Wall St ·
- Kymera Therapeutics, Inc. (KYMR) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Kymera Therapeutics to present at five September investor conferences
scanx.trade ·
- Clinical Progress May Keep Kymera Therapeutics Stock In Focus Despite Losses
Simply Wall St ·
- Kymera Therapeutics (KYMR) Stock May Be Overvalued Following Positive KT 579 Data
Yahoo Finance ·
- Kymera Therapeutics, Inc. (KYMR) - What Are Brokerages Saying About This Stock?
MarketBeat ·
- Kymera Therapeutics stock hits all-time high at 130.48 USD By Investing.com
Investing.com South Africa ·
- Kymera Therapeutics, Inc. Q3 2026 Earnings Call Summary
app.moby.co ·
- Kymera (KYMR) Q3 2026 Earnings Call Transcript
fool.com ·
- Kymera Therapeutics Q3 Earnings Call Highlights
marketbeat.com ·
Kymera Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $39.2M | $47.1M | $78.6M | $46.8M |
| Net income | $311.4M | $223.9M | $147.0M | $154.8M |
| Diluted EPS | $-3.69 | $-2.98 | $-2.52 | $-2.87 |
| Total assets (year end) | $1.74B | $978.0M | $575.8M | $603.1M |
| Cash and equivalents (year end) | $357.0M | $120.3M | $110.0M | $68.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Kymera Therapeutics, Inc.
- Ticker
- KYMR (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Watertown, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1815442
- Former names
- Kymera Therapeutics, Inc.
Frequently asked questions
What exchange is Kymera Therapeutics, Inc. listed on?
Kymera Therapeutics, Inc. trades on the Nasdaq under the ticker symbol KYMR.
What industry is Kymera Therapeutics, Inc. in?
Kymera Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Kymera Therapeutics, Inc. headquartered?
Kymera Therapeutics, Inc.'s business address on file with the SEC is in Watertown, MA.
When does Kymera Therapeutics, Inc.'s fiscal year end?
Kymera Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Kymera Therapeutics, Inc. report?
Kymera Therapeutics, Inc. reported $39.2M in revenue for calendar year 2025, according to its SEC filings.